Medical Devices Investors & VC Firms in Japan
94 firms in this list, with a median first check of $500K. 16 of them lead rounds. Generated from verified public data and updated continuously.
NIPPON EXPRESS HOLDINGS
Seed–Series B
Capital Medica Ventures
TokyoPre-Seed–Growth
3 people
Omron Ventures
KyotoSeed–Growth
2 people
FFG Venture Business Partners
FukuokaPre-Seed–Growth
1 person
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
Global Venture Capital, Inc.
TokyoSeed–Series A
2 people
Tohoku Innovation Capital Corporation
MiyagiSeed–Series A
2 people
Venture Labo Investment
TokyoSeed–Series A
Alumni Ventures
ManchesterPre-Seed–Late Stage$100K – $10M
111 people
Khosla Ventures
Menlo ParkPre-Seed–Growth$100K – $20M
49 people
HongShan Capital Group
Hong KongSeed–Growth$100K – $50M
89 people
SBI Investment Korea Co. Ltd.
SeoulSeries A–Series C$200K – $10M
33 people
Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
82 people
EQT Life Sciences
AmsterdamSeed–Late Stage$11M – $66M
59 people
Eight Roads Ventures
MumbaiSeed–Growth$5M – $30M
33 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
15 people
Seventure Partners
ParisSeed–Growth
19 people
Taiwania Capital
TaipeiSeed–Growth
49 people
GoAhead Ventures
Menlo ParkPre-Seed–Seed$500K – $1M
12 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
Vertex Ventures China
SingaporePre-Seed–Series A
6 people
ARCHIMED Japan
LyonGrowth–Late Stage$10.8M – $1.1B
22 people
Samsung Ventures
SeoulSeries A
26 people
TEL Venture Capital, Inc.
FremontPre-Seed–Growth
26 people
Related lists
Investors & VC Firms in North America (12952)Investors & VC Firms in United States (11990)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.






























































